Expression of nuclear transcription factor kappa b in locally advanced human cervical cancer treated with definitive chemoradiation

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 5, 2010, Pages 1331-1336

  Garg, Amit K ^a   Jhingran, Anuja ^a   Klopp, Ann H ^a   Aggarwal, Bharat B ^a   Kunnumakkara, Ajai B ^a   Broadus, Russell R ^a   Eifel, Patricia J ^a   Buchholz, Thomas A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Cervical cancer; Chemotherapy; Nuclear transcription factor kappa B; Radiation

Indexed keywords

AFTER-TREATMENT; CERVICAL CANCERS; CHEMORADIATION; CONSTITUTIVELY ACTIVES; IMMUNOHISTOCHEMICAL STAINING; NUCLEAR FACTOR KAPPAB; NUCLEAR TRANSCRIPTION FACTORS; PRE-TREATMENT; RADIATION THERAPY; REGIONAL FAILURES; TRANSCRIPTIONAL FACTORS; TREATMENT FAILURE;

BIOPSY; CHEMOTHERAPY; PATIENT MONITORING; TRANSCRIPTION; TRANSCRIPTION FACTORS;

RADIOTHERAPY;

CISPLATIN; FLUOROURACIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CORRELATION ANALYSIS; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER;

ADULT; AGED; BIOPSY; CARCINOMA, SQUAMOUS CELL; CERVIX UTERI; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; NF-KAPPA B; PILOT PROJECTS; PROGNOSIS; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 78549240541     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.09.044     Document Type: Article

References (26)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2008 CA Cancer J Clin 58 2008 71 96
2. P.J. Eifel, K. Winter, and M. Morris Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01 J Clin Oncol 22 2004 872 880
3. M. Morris, P.J. Eifel, and J. Lu Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1999 1137 1143
4. R. Pearcey, M. Brundage, and P. Drouin Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix J Clin Oncol 20 2002 966 972
5. M.M. Leitao Jr., and D.S. Chi Recurrent cervical cancer Curr Treat Options Oncol 3 2002 105 111
6. A. Garg, and B.B. Aggarwal Nuclear transcription factor-kappaB as a target for cancer drug development Leukemia 16 2002 1053 1068
7. A. Nair, M. Venkatraman, and T.T. Maliekal NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix Oncogene 22 2003 50 58
8. B.K. Prusty, S.A. Husain, and B.C. Das Constitutive activation of nuclear factor-kB: Preferential homodimerization of p50 subunits in cervical carcinoma Front Biosci 10 2005 1510 1519
9. A.K. Garg, T.A. Buchholz, and B.B. Aggarwal Chemosensitization and radiosensitization of tumors by plant polyphenols Antioxid Redox Signal 7 2005 1630 1647
10. J.L. Luo, H. Kamata, and M. Karin IKK/NF-kappaB signaling: Balancing life and death - A new approach to cancer therapy J Clin Invest 115 2005 2625 2632
11. J.M. del Campo, A. Prat, and A. Gil-Moreno Update on novel therapeutic agents for cervical cancer Gynecol Oncol 110 2008 S72 S76
12. T.A. Buchholz, A.K. Garg, and N. Chakravarti The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer Clin Cancer Res 11 2005 8398 8402
13. V. Fradet, L. Lessard, and L.R. Begin Nuclear factor-kappaB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer Clin Cancer Res 10 2004 8460 8464
14. K. Gao, D.L. Dai, and M. Martinka Prognostic significance of nuclear factor-kappaB p105/p50 in human melanoma and its role in cell migration Cancer Res 66 2006 8382 8388
15. X. Jin, Z. Wang, and L. Qiu Potential biomarkers involving IKK/RelA signal in early stage non-small cell lung cancer Cancer Sci 99 2008 582 589
16. W. Weichert, M. Boehm, and V. Gekeler High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis Br J Cancer 97 2007 523 530
17. A.H. Klopp, A. Jhingran, and L. Ramdas Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome Int J Radiat Oncol Biol Phys 71 2008 226 236
18. M.P. Charalambous, T. Lightfoot, and V. Speirs Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue Br J Cancer 101 2009 106 115
19. I. Espinosa, J. Briones, and R. Bordes Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: Clinical implications Histopathology 53 2008 441 449
20. Y.M. Long, S. Ye, and J. Rong Nuclear factor kappa B: A marker of chemotherapy for human stage IV gastric carcinoma World J Gastroenterol 14 2008 4739 4744
21. K.M. Ahmed, N. Cao, and J.J. Li HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer Anticancer Res 26 2006 4235 4243
22. C.Y. Wang, M.W. Mayo, and A.S. Baldwin Jr. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB Science 274 1996 784 787
23. S. Kamer, Q. Ren, and A.P. Dicker Differential radiation sensitization of human cervical cancer cell lines by the proteasome inhibitor velcade (bortezomib, PS-341) Arch Gynecol Obstet 279 2009 41 46
24. L. Ashall, C.A. Horton, and D.E. Nelson Pulsatile stimulation determines timing and specificity of NF-kappaB-dependent transcription Science 324 2009 242 246
25. M. Branca, C. Giorgi, and M. Ciotti Upregulation of nuclear factor-kappaB (NF-kappaB) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus or disease outcome in cervical cancer Diagn Cytopathol 34 2006 555 563
26. S.H. Kim, J.M. Oh, and J.H. No Involvement of NF-kappaB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein Carcinogenesis 30 2009 753 757